AbbVie
ABBV
#27
Rank
A$689.41 B
Marketcap
A$390.13
Share price
0.39%
Change (1 day)
10.70%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): A$12.75 Billion

According to AbbVie's latest financial reports the company's current earnings are A$64.38 Billion. In 2025 the company made an earning of A$9.44 Billion, an increase over its 2024 earnings that were of A$5.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$12.75 B34.99%
2025 A$9.44 B77.53%
2024 A$5.32 B-40.54%
2023 A$8.95 B-53.62%
2022 A$19.30 B3.76%
2021 A$18.60 B282.25%
2020 A$4.86 B-59.67%
2019 A$12.06 B62.13%
2018 A$7.44 B-32.74%
2017 A$11.06 B-1.99%
2016 A$11.29 B18.65%
2015 A$9.51 B180.5%
2014 A$3.39 B-55.57%
2013 A$7.63 B-6.86%
2012 A$8.19 B56.05%
2011 A$5.25 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$9.89 B-20.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$48.11 B 286.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.73 B 18.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$1.44 B-88.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-A$2.8 Billion-122.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$17.05 B 36.91%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.52 B 64.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$11.29 B-9.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$1.17 B-90.59%๐Ÿ‡บ๐Ÿ‡ธ USA